期刊
ANTICANCER RESEARCH
卷 37, 期 2, 页码 377-387出版社
INT INST ANTICANCER RESEARCH
DOI: 10.21873/anticanres.11330
关键词
Non-small cell lung cancer; immunotherapy; checkpoint; inhibitors; vaccine; review
类别
Lung cancer is the leading cause of cancerrelated death worldwide. Treatment of non-small cell lung cancer has evolved tremendously over the past decade. Specifically, immune checkpoint inhibitors have become an increasingly interesting target of pharmacological blockade. These immune inhibitors have shown promising results in front-line therapy and after failure of multiple lines, as well as in monotherapy and combination with other therapies. Vaccination in non-small cell lung cancer is also an emerging field of research that holds promising results for the future of immunotherapy in non-small cell lung cancer. This review presents a concise update on the most recent data regarding the role of checkpoint inhibitors as well as vaccination in non-small cell lung cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据